Cargando…

Clinical Markers of Anxiety Subtypes in Parkinson Disease

OBJECTIVE: The aim of this work was to investigate marker profiles for proposed anxiety subtypes in Parkinson disease (PD). METHODS: We used the persistent anxiety, episodic anxiety, and avoidance behavior subscales of the Parkinson Anxiety Scale as dependent variables in multivariable linear regres...

Descripción completa

Detalles Bibliográficos
Autores principales:	Broen, Martinus P. G., Leentjens, A. F. G., Hinkle, J. T., Moonen, A. J. H., Kuijf, M. L., Fischer, N. M., Perepezko, K., Bakker, A., Pontone, G. M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2018
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903060/ https://www.ncbi.nlm.nih.gov/pubmed/29528763 http://dx.doi.org/10.1177/0891988718757369

Ejemplares similares

Cognitive Behavioral Therapy for Anxiety in Parkinson’s Disease Induces Functional Brain Changes
por: Carey, Guillaume, et al.
Publicado: (2023)

Unraveling the Relationship between Motor Symptoms, Affective States and Contextual Factors in Parkinson’s Disease: A Feasibility Study of the Experience Sampling Method
por: Broen, Martijn P. G., et al.
Publicado: (2016)

Usability of the Experience Sampling Method in Parkinson's Disease on a Group and Individual Level
por: Mulders, Anne E.P., et al.
Publicado: (2020)

Cognitive Behavioral Therapy for Anxiety in Parkinsonʼs Disease: A Randomized Controlled Trial
por: Moonen, Anja J.H., et al.
Publicado: (2021)

Neuroimaging of Anxiety in Parkinson's Disease: A Systematic Review
por: Carey, Guillaume, et al.
Publicado: (2020)

The TRACK-PD study: protocol of a longitudinal ultra-high field imaging study in Parkinson’s disease
por: Wolters, A. F., et al.
Publicado: (2020)

Anxiety in Parkinson’s Disease Is Associated with Changes in Brain Structural Connectivity
por: Carey, Guillaume, et al.
Publicado: (2023)

Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
por: Pontone, Gregory M., et al.
Publicado: (2019)

Author Correction: Report from a multidisciplinary meeting on anxiety as a non-motor manifestation of Parkinson’s disease
por: Pontone, Gregory M., et al.
Publicado: (2020)

An fMRI study into emotional processing in Parkinson’s disease: Does increased medial prefrontal activation compensate for striatal dysfunction?
por: Moonen, Anja J. H., et al.
Publicado: (2017)

Mobile Health Daily Life Monitoring for Parkinson Disease: Development and Validation of Ecological Momentary Assessments
por: Habets, Jeroen, et al.
Publicado: (2020)

Functional connectivity disruptions correlate with cognitive phenotypes in Parkinson's disease
por: Hassan, M., et al.
Publicado: (2017)

Parkinson’s Disease Subtypes: Critical Appraisal and Recommendations
por: Mestre, Tiago A., et al.
Publicado: (2021)

Cognitive Function in Parkinson's Disease Patients with and without Anxiety
por: Ehgoetz Martens, K. A., et al.
Publicado: (2016)

Parkinson disease clinical subtypes: key features & clinical milestones
por: Campbell, Meghan C., et al.
Publicado: (2020)

Association of Plasma and Electroencephalography Markers With Motor Subtypes of Parkinson’s Disease
por: Yang, Xiaoxia, et al.
Publicado: (2022)

Corrigendum to “The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease” [Contemp. Clinic. Trials Commun. 32 (2023) 101080]
por: Erga, Aleksander H., et al.
Publicado: (2023)

Mother and daughter with a SMARCE1 mutation resulting in a cervical clear cell meningioma at an identical location: illustrative cases
por: Schuermans, Valérie N. E., et al.
Publicado: (2023)

Does Anxiety Cause Freezing of Gait in Parkinson's Disease?
por: Ehgoetz Martens, Kaylena A., et al.
Publicado: (2014)

The ePark study protocol: A decentralized trial of individual video-assisted cognitive behavioural therapy for depressive disorder in Parkinson's disease
por: Erga, Aleksander H., et al.
Publicado: (2023)

Genetics of validated Parkinson’s disease subtypes in the Oxford Discovery and Tracking Parkinson’s cohorts
por: Lawton, Michael, et al.
Publicado: (2022)

Distinct progression patterns across Parkinson disease clinical subtypes
por: Myers, Peter S., et al.
Publicado: (2021)

Developing and validating Parkinson’s disease subtypes and their motor and cognitive progression
por: Lawton, Michael, et al.
Publicado: (2018)

Biomarker characterization of clinical subtypes of Parkinson Disease
por: Deng, Xiao, et al.
Publicado: (2022)

Anxiety After Stroke: The Importance of Subtyping
por: Chun, Ho-Yan Yvonne, et al.
Publicado: (2018)

Emerging Targeted Therapeutics for Genetic Subtypes of Parkinsonism
por: Schneider, Susanne A., et al.
Publicado: (2020)

Myelotoxicity of Temozolomide Treatment in Patients with Glioblastoma Is It Time for a More Mechanistic Approach?
por: Said, Medhat M., et al.
Publicado: (2023)

Parkinson Subtypes Progress Differently in Clinical Course and Imaging Pattern
por: Eggers, Carsten, et al.
Publicado: (2012)

Change in the Parkinson Anxiety Scale correlates with change in other clinical measures of anxiety over time
por: Schneider, Ruth B., et al.
Publicado: (2021)

Dopamine Transporter Imaging in Psychogenic Parkinsonism and Neurodegenerative Parkinsonism with Psychogenic Overlay: A Report of Three Cases
por: Umeh, Chizoba C., et al.
Publicado: (2013)

Prevalence and Subtypes of Mild Cognitive Impairment in Parkinson’s Disease
por: Lawrence, Blake J., et al.
Publicado: (2016)

Two-year clinical progression in focal and diffuse subtypes of Parkinson’s disease
por: Johansson, Martin E., et al.
Publicado: (2023)

Parkinsonism in Genetic Neurodevelopmental Disorders: A Systematic Review
por: von Scheibler, Emma N.M.M., et al.
Publicado: (2022)

Inflammation and tissue repair markers distinguish the nodular sclerosis and mixed cellularity subtypes of classical Hodgkin's lymphoma
por: Birgersdotter, A, et al.
Publicado: (2009)

Genetic architecture of Parkinson’s disease subtypes – Review of the literature
por: Dulski, Jarosław, et al.
Publicado: (2022)

Systematic review of data‐driven cognitive subtypes in Parkinson disease
por: Pourzinal, Dana, et al.
Publicado: (2022)

Serum Neurofilament Light Chain as a Marker of Progression in Parkinson’s Disease: Long-Term Observation and Implications of Clinical Subtypes
por: Ygland Rödström, Emil, et al.
Publicado: (2022)

Neural and behavioral substrates of subtypes of Parkinson’s disease
por: Moustafa, Ahmed A., et al.
Publicado: (2013)

An update on adaptive deep brain stimulation in Parkinson's disease
por: Habets, Jeroen G.V., et al.
Publicado: (2018)

Does Anxiety or Waiting Time Influence Patients' Tolerance of Upper Endoscopy?
por: Pontone, Stefano, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_6l3u38sr9fr0n87b638l0cqidd